Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Open in API
Filings indexed 2,323 across all filing types
Latest filing 2024-08-13 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
FORM 6K
Regulatory Filings
2024-08-13 English
Notice of Postal Ballot
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Dr. Reddy's Laboratories Limited dated August 13, 2024. It is addressed to stock exchanges and shareholders, informing them about the postal ballot process for approval of a share subdivision (split of equity shares). The notice includes details about the voting process, cut-off dates, regulatory references (Companies Act, SEBI Listing Regulations), and instructions for electronic voting. It does not contain financial statements or results but is a formal notice seeking shareholder approval for a corporate action related to capital structure. This fits the definition of a Proxy Solicitation & Information Statement (PSI), as it is material sent to shareholders to provide information and request votes for a meeting or resolution. The document is lengthy (15,000 characters) and contains the full notice, not just an announcement of a report. Therefore, the correct classification is PSI with high confidence.
2024-08-13 English
FORM 6-K
Regulatory Filings
2024-08-12 English
Update on the USFDA inspection at the Company''s formulations manufacturing facilities (FTO -7 & FTO-9) in Duvvada, Visakhapatnam
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding an update on a USFDA inspection at the company's manufacturing facilities. It references a previous intimation and provides the status of the inspection (classified as Voluntary Action Indicated and closed). The document is brief (1279 characters) and serves as an official regulatory update rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed audit information. It is an announcement under SEBI regulations providing regulatory compliance information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-12 English
FORM 6-K
Regulatory Filings
2024-08-07 English
Allotment of equity shares on exercise of Employee Stock Options
Share Issue/Capital Change Classification · 95% confidence The document is a formal disclosure addressed to multiple stock exchanges regarding the allotment of equity shares upon exercise of stock options under the company's ESOP scheme. It references compliance with SEBI regulations and provides detailed information about the share allotment, exercise prices, and share capital changes. There are no financial statements, earnings data, or management discussion of results. The document is an announcement of a capital change event (allotment of shares due to stock options exercise). Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement but a detailed disclosure, supporting a high confidence classification.
2024-08-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.